phrykt

Core Scientific, Inc./tx (CORZ): who owns it and who trades it

As of Nov 16, 2026, CORZ insiders reported 53 open-market sales worth $6.6M and 4 purchases worth $444K in the last 12 months, with 13% of the sale value made under pre-set 10b5-1 plans. The largest seller was Todd M Duchene (See remarks), with $6.6M. 8 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Core Scientific

From the latest filings

Overall: more selling than buying. Insiders mostly sold. Funds and famous investors were close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns CORZ

412 funds and institutions reported CORZ shares worth $9.7B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 8.8%.

Funds and institutions (13F) about 100%Everyone else 0%

10 largest owners, by share of the company

BlackRock, Inc.8.8%
Situational Awareness LP8.2%
Jericho Capital Asset Management L.P.7.2%
Vanguard Portfolio Management LLC5.9%
UBS Group AG5.0%
Vanguard Capital Management LLC4.3%
Two Sigma Investments, LP3.2%
Value Aligned Research Advisors, LLC2.9%
Two Seas Capital LP2.8%
Geode Capital Management, LLC2.7%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.28.12M8.85%$720M+14%
Situational Awareness LP26.01M8.18%$666MNo change
Jericho Capital Asset Management L.P.22.88M7.20%$586M+95%
Vanguard Portfolio Management LLC18.66M5.87%$478M+0%
UBS Group AG15.89M5.00%$407M-38%
Vanguard Capital Management LLC13.80M4.34%$353M+3%
Two Sigma Investments, LP10.28M3.23%$263M+84%
Value Aligned Research Advisors, LLC9.19M2.89%$235M+19%
Two Seas Capital LP9.03M2.84%$231M-44%
Geode Capital Management, LLC8.50M2.67%$245M+9%
State Street Corp7.75M2.44%$198M+6%
California State Teachers Retirement System7.48M2.35%$292M–
Valiant Capital Management, L.P.7.47M2.35%$191M+9%
Ascentis Wealth Management, LLC7.28M2.29%$186MNo change
Jane Street Group, LLC6.47M2.04%$166M–
Morgan Stanley6.34M1.99%$162M+83%
T. Rowe Price Associates6.22M1.96%$159M+779%
Alliancebernstein L.P.5.62M1.77%$84.1M–
JPMorgan Chase & Co5.45M1.72%$142M–
Oaktree Capital Management LP4.99M1.57%$128M-47%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, CORZ insiders reported $444K of open-market purchases and $6.6M of sales. 13% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$444K
4 trades, 2 people
Sales, 12 months
$6.6M
53 trades, 1 people
Sales under a 10b5-1 plan
13%
Share of sale value
Latest trade
Nov 9, 2026
Filed Nov 12, 2026

Purchases and sales by month

$1.4M$1.4MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 9, 2026Todd M DucheneSee remarksSale plan7,900$12.39$97.9KForm 4
Nov 9, 2026Todd M DucheneSee remarksSale plan2,100$12.70$26.7KForm 4
Nov 2, 2026Todd M DucheneSee remarksSale plan9,900$12.78$126KForm 4
Nov 2, 2026Todd M DucheneSee remarksSale plan100$13.37$1.3KForm 4
Oct 26, 2026Todd M DucheneSee remarksSale plan4,500$13.27$59.7KForm 4
Oct 26, 2026Todd M DucheneSee remarksSale plan5,500$13.80$75.9KForm 4
Oct 19, 2026Todd M DucheneSee remarksSale plan10,000$13.87$139KForm 4
Oct 12, 2026Todd M DucheneSee remarksSale plan10,000$15.12$151KForm 4
Oct 5, 2026Todd M DucheneSee remarksSale plan10,000$16.31$163KForm 4
Sep 28, 2026Todd M DucheneSee remarksSale10,000$16.76$168KForm 4
Sep 21, 2026Todd M DucheneSee remarksSale10,000$18.37$184KForm 4
Sep 15, 2026Eric Stanton WeissDirectorPurchase6,000$16.33$98KForm 4
Sep 14, 2026Todd M DucheneSee remarksSale10,000$17.14$171KForm 4
Sep 8, 2026Todd M DucheneSee remarksSale10,000$18.67$187KForm 4
Aug 31, 2026Todd M DucheneSee remarksSale10,000$16.23$162KForm 4
Aug 24, 2026Todd M DucheneSee remarksSale10,000$17.45$174KForm 4
Aug 20, 2026Elizabeth CrainDirectorPurchase6,000$18.33$110KForm 4
Aug 18, 2026Eric Stanton WeissDirectorPurchase7,000$19.19$134KForm 4
Aug 17, 2026Todd M DucheneSee remarksSale10,000$20.10$201KForm 4
Aug 10, 2026Todd M DucheneSee remarksSale9,000$19.90$179KForm 4
Aug 10, 2026Todd M DucheneSee remarksSale1,000$20.65$20.6KForm 4
Aug 3, 2026Todd M DucheneSee remarksSale7,500$22.62$170KForm 4
Aug 3, 2026Todd M DucheneSee remarksSale1,500$21.55$32.3KForm 4
Aug 3, 2026Todd M DucheneSee remarksSale1,000$20.39$20.4KForm 4
Jul 27, 2026Todd M DucheneSee remarksSale100$22.49$2.2KForm 4
Jul 27, 2026Todd M DucheneSee remarksSale1,600$21.89$35KForm 4
Jul 27, 2026Todd M DucheneSee remarksSale8,300$20.75$172KForm 4
Jul 20, 2026Todd M DucheneSee remarksSale10,000$22.30$223KForm 4
Jul 13, 2026Todd M DucheneSee remarksSale300$23.01$6.9KForm 4
Jul 13, 2026Todd M DucheneSee remarksSale9,700$22.43$218KForm 4
Jul 6, 2026Todd M DucheneSee remarksSale10,000$22.63$226KForm 4
Jun 29, 2026Todd M DucheneSee remarksSale8,800$25.99$229KForm 4
Jun 29, 2026Todd M DucheneSee remarksSale100$27.95$2.8KForm 4
Jun 29, 2026Todd M DucheneSee remarksSale1,100$27.42$30.2KForm 4
Jun 22, 2026Todd M DucheneSee remarksSale7,600$29.11$221KForm 4
Jun 22, 2026Todd M DucheneSee remarksSale2,400$29.88$71.7KForm 4
Jun 15, 2026Todd M DucheneSee remarksSale100$28.79$2.9KForm 4
Jun 15, 2026Todd M DucheneSee remarksSale9,900$28.19$279KForm 4
Jun 8, 2026Todd M DucheneSee remarksSale5,500$26.64$147KForm 4
Jun 8, 2026Todd M DucheneSee remarksSale4,500$27.11$122KForm 4
Jun 1, 2026Todd M DucheneSee remarksSale5,500$28.76$158KForm 4
Jun 1, 2026Todd M DucheneSee remarksSale3,200$28.27$90.5KForm 4
Jun 1, 2026Todd M DucheneSee remarksSale1,300$26.93$35KForm 4
May 26, 2026Todd M DucheneSee remarksSale10,000$26.25$262KForm 4
May 18, 2026Todd M DucheneSee remarksSale9,600$23.12$222KForm 4
May 18, 2026Todd M DucheneSee remarksSale400$23.76$9.5KForm 4
May 11, 2026Todd M DucheneSee remarksSale2,600$22.82$59.3KForm 4
May 11, 2026Todd M DucheneSee remarksSale7,400$23.39$173KForm 4
May 4, 2026Todd M DucheneSee remarksSale9,900$20.85$206KForm 4
May 4, 2026Todd M DucheneSee remarksSale100$21.53$2.2KForm 4
Apr 27, 2026Todd M DucheneSee remarksSale10,000$20.94$209KForm 4
Apr 20, 2026Todd M DucheneSee remarksSale10,000$19.80$198KForm 4
Apr 13, 2026Todd M DucheneSee remarksSale400$18.99$7.6KForm 4
Apr 13, 2026Todd M DucheneSee remarksSale9,600$18.61$179KForm 4
Apr 6, 2026Todd M DucheneSee remarksSale10,000$16.49$165KForm 4
Apr 1, 2026Todd M DucheneSee remarksSale10,000$15.25$152KForm 4
Mar 9, 2026Eric Stanton WeissDirectorPurchase7,000$14.53$102KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Todd M DucheneSee remarks–$6.6MNov 9, 2026
Eric Stanton WeissDirector$334K–Sep 15, 2026
Elizabeth CrainDirector$110K–Aug 20, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

CORZ short interest

Very high short interest. 22.7% of CORZ shares are sold short: about 1 share in 4. Over the last 12 reports the number of shares short went up 14%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 73.01M CORZ shares were sold short, 22.7% of the shares outstanding, down 4.7% from the report before. At the average daily volume of 14.47M shares, buying them all back would take about 5.0 trading days (days to cover).

Shares short, % of all shares

22.7%May 15Oct 3024.5%

Days to cover

5.0May 15Oct 306.6

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202673.01M22.72%-5%14.47M5.0
Oct 15, 202676.63M23.85%+16%14.85M5.2
Sep 30, 202665.99M20.54%+5%11.39M5.8
Sep 15, 202663.13M19.65%-3%10.78M5.9
Aug 31, 202664.79M20.16%+2%11.02M5.9
Aug 14, 202663.44M19.74%+0%12.34M5.1
Jul 31, 202663.14M19.65%-0%13.82M4.6
Jul 15, 202663.36M19.93%-8%11.03M5.7
Jun 30, 202669.09M21.74%-8%12.39M5.6
Jun 15, 202674.72M23.51%+4%12.05M6.2
May 29, 202671.85M22.60%+12%13.25M5.4
May 15, 202664.07M20.16%-2%18.00M3.6

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Core Scientific company events

Core Scientific filed 20 reports on Form 8-K in the last 12 months, 6 of them about an important change (leadership, restatement). The latest was on Nov 5, 2026.

  1. Nov 5, 2026ResultsReleased financial results. Filing
  2. Sep 10, 2026AnnouncementShared information with investors. Filing
  3. Aug 27, 2026AgreementCore Scientific, Inc. entered into a Credit Agreement, among the Company, as borrower, each issuing bank and lender party thereto from time to time, JPMorgan Chase Bank, N.A. as administrative agent and collateral agent. Filing
  4. Aug 14, 2026AnnouncementCore Scientific, Inc., a Delaware corporation, completed the previously announced acquisition of Polaris DS LLC, a Nevada limited liability company, contemplated by the Agreement and Plan of Merger, dated as of May 5, 2026, by and among the Company, Polar Merger Sub, LLC, a Nevada limited liability… Filing
  5. Jul 29, 2026LeadershipThe Company announced the appointment of Mark W. Adams, as a member of the Board of Directors, effective immediately. Filing
  6. Jul 28, 2026ResultsReleased financial results. Filing
  7. Jul 28, 2026SharesSold new shares outside a public offering. Filing
  8. May 26, 2026LeadershipThe Company announced the appointment of Steve M. Smith, as a member of the Board and the Nominating and Corporate Governance Committee of the Board, effective immediately. Filing
  9. May 15, 2026VoteReported shareholder vote results. Filing
  10. May 6, 2026ResultsReleased financial results. Filing
  11. May 6, 2026AgreementCore Scientific Finance I LLC, a wholly-owned indirect subsidiary of Core Scientific, Inc., completed its previously announced private offering of $3.3 billion of its 7.750% Senior Secured Notes due 2031. Filing
  12. May 6, 2026AgreementCore Scientific, Inc., a Delaware corporation, entered into an agreement and plan of merger with Polar Merger Sub, LLC, a Nevada limited liability company and wholly owned subsidiary of the Company, Polaris DS LLC, a Nevada limited liability company, Top Access Enterprises Limited, a company… Filing
  13. May 5, 2026LeadershipThe Board of Directors of Core Scientific, Inc. appointed Jorge Ray as the Company’s Principal Accounting Officer, effective May 7, 2026. Filing
  14. Apr 27, 2026AnnouncementShared information with investors. Filing
  15. Apr 21, 2026AnnouncementShared information with investors. Filing
  16. Mar 23, 2026AgreementCore Scientific, Inc. entered into Amendment No. 1 to Delayed-Draw Bridge Credit Agreement, by and among the Company, as borrower, Morgan Stanley Senior Funding, Inc., as administrative agent and collateral agent (in such capacity, the “Agent”), and JPMorgan Chase Bank, N.A., as amendment no. 1… Filing
  17. Mar 6, 2026AgreementCore Scientific, Inc. entered into a loan facility Credit Agreement, by and among the Company, as borrower, the lenders party thereto from time to time and Morgan Stanley Senior Funding, Inc., as administrative agent and collateral agent. Filing
  18. Mar 2, 2026RestatementThe Audit Committee of the Board of Directors of the Company, in consultation with management, determined that the Company’s consolidated financial statements for the three and six months ended June 30, 2024, the three and nine months ended September 30, 2024, the year ended December 31, 2024, the… Filing
  19. Feb 19, 2026LeadershipAmended an earlier report. Separately, at regularly scheduled meeting of the Company’s Board of Directors held on February 18, 2026, Jordan Levy, the Chairman of the Board of Directors, notified the Company and the Board of Directors that he will not stand for re-election at the 2026 Annual Meeting. Filing
  20. Feb 18, 2026LeadershipJordan Levy, the Chairman of the Board of Directors, notified the Company and the Board of Directors that he will not stand for re-election at the 2026 Annual Meeting. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Core Scientific financials

Famous investors that hold CORZ

8 of the 50 well-known investors we track reported holding CORZ in their latest 13F filing. The largest position is Howard Marks's, worth $128M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Howard Marks · Oaktree Capital ManagementQ2 20264.99M$128M3.4%-47%
Steve Cohen · Point72 Asset ManagementQ3 20269.17M$85.2M0.1%-1%
Ken Griffin · Citadel AdvisorsQ3 20264.19M$67M0.0%+4%
Jim Simons · Renaissance TechnologiesQ3 20263.56M$56.9M0.1%+7%
Israel Englander · Millennium ManagementQ3 20262.74M$43.8M0.0%-22%
Paul Tudor Jones · Tudor Investment CorpQ3 20261.82M$29.1M0.1%-16%
Larry Robbins · Glenview Capital ManagementQ3 20261.59M$25.4M0.5%New
George Soros · Soros Fund ManagementQ3 20262.25M$21M0.4%No change

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 6 filings named CORZ in the last 120 days.

FiledHolderFormStake
Nov 16, 2026Citadel Securities GP LLC13G/A3.5%
Nov 16, 2026Citadel Securities GP LLC13G/A3.5%
Nov 6, 2026JANE STREET GROUP, LLC13G/A2.9%
Nov 6, 2026JANE STREET GROUP, LLC13G/A2.9%
Oct 28, 2026MFN Partners, LP13G7.6%
Oct 28, 2026MFN Partners, LP13G7.6%

Questions about Core Scientific, Inc./tx (CORZ) stock

Who owns the most CORZ stock?

The largest reported owner of Core Scientific, Inc./tx (CORZ) is BlackRock, Inc., with 8.8% of the company. In total, 412 funds and institutions reported holding CORZ at the end of Q2 2026, together about 100% of the shares. See the largest owners.

Are CORZ insiders buying or selling?

In the last 12 months, CORZ insiders reported 4 open-market purchases worth $444K and 53 sales worth $6.6M. The latest trade was on Nov 9, 2026. See every trade.

What is the short interest in CORZ?

As of Oct 30, 2026, 73.01M CORZ shares were sold short, 22.7% of the shares outstanding, down 4.7% from the report before. At the average daily volume of 14.47M shares, buying them all back would take about 5.0 trading days (days to cover). See the history.

Which famous investors hold CORZ?

8 of the 50 well-known investors we track reported CORZ in their latest 13F filing, including Howard Marks, Steve Cohen, Ken Griffin. The largest position is worth $128M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.